|
NL297170A
(enExample)
*
|
1963-04-04 |
1900-01-01 |
|
|
|
NL128365C
(enExample)
|
1963-11-05 |
|
|
|
|
US3449427A
(en)
*
|
1965-06-03 |
1969-06-10 |
Smithkline Corp |
Aminocyclopropane derivatives of 5h-dibenzo(a,d)cycloheptenes
|
|
US3697506A
(en)
|
1970-08-07 |
1972-10-10 |
Pfizer |
Crystalline alkali metal salts of {60 -carboxybenzylpenicillin and process therefor
|
|
US3686335A
(en)
*
|
1970-12-21 |
1972-08-22 |
Smith Kline French Lab |
5-vinyl-5h-di benzo(a,d)cycloheptenes
|
|
US4432987A
(en)
|
1982-04-23 |
1984-02-21 |
Pfizer Inc. |
Crystalline benzenesulfonate salts of sultamicillin
|
|
US4547505A
(en)
|
1983-03-25 |
1985-10-15 |
Degussa Aktiengesellschaft |
N-Phenyl-N-'-cycloalkylalkanoylpiperazine useful as analgetics and process for its production
|
|
CS244821B2
(en)
|
1983-06-16 |
1986-08-14 |
Boehringer Ingelheim Ltd |
Production method of new substituted phenylalkyl(piperazinyl or homopiperazinyle)-prpylureas or thioureas
|
|
DE3418167A1
(de)
|
1984-05-16 |
1985-11-21 |
Bayer Ag, 5090 Leverkusen |
Verwendung von amiden zur verbesserung der kulturpflanzen-vertraeglichkeit von herbizid wirksamen heteroaryloxyacetamiden
|
|
DE3600288A1
(de)
|
1986-01-08 |
1987-07-16 |
Bayer Ag |
Verwendung von amiden zur verbesserung der kulturpflanzen-vertraeglichkeit von herbizid wirksamen sulfonylharnstoff-derivaten
|
|
DE3618004A1
(de)
|
1986-05-28 |
1987-12-03 |
Bayer Ag |
Verwendung von amiden zur verbesserung der kulturpflanzen-vertraeglichkeit von herbizid wirksamen sulfonyliso(thio)-harnstoff-derivaten
|
|
AU658134B2
(en)
|
1989-12-28 |
1995-04-06 |
Virginia Commonwealth University |
Sigma receptor ligands and the use thereof
|
|
EP0435320B1
(en)
*
|
1989-12-29 |
1994-10-05 |
Banyu Pharmaceutical Co., Ltd. |
2(2-Cyclopropylpyrrolidin-4-ylthio)-carbapenem derivatives
|
|
WO1993003615A1
(en)
|
1991-08-22 |
1993-03-04 |
Monsanto Company |
Safening herbicidal pyrazolylsulfonylures
|
|
DE4131139A1
(de)
|
1991-09-19 |
1993-03-25 |
Bayer Ag |
Verfahren zur herstellung von 1-fluor-cyclopropan-1-carbonsaeure
|
|
WO1994020505A1
(en)
|
1993-03-12 |
1994-09-15 |
The Upjohn Company |
Crystalline ceftiofur free acid
|
|
CN1088062C
(zh)
|
1994-11-23 |
2002-07-24 |
纽罗根公司 |
某些4－氨基甲基－2－取代的咪唑衍生物2－氨基甲基－4－取代的咪唑衍生物新的一族多巴胺受体亚型特异性配体
|
|
US5604253A
(en)
|
1995-05-22 |
1997-02-18 |
Merck Frosst Canada, Inc. |
N-benzylindol-3-yl propanoic acid derivatives as cyclooxygenase inhibitors
|
|
US5859246A
(en)
|
1997-01-30 |
1999-01-12 |
Neurogen Corporation |
1-phenyl-4-benzylpiperazines: dopamine receptor subtype specific ligands
|
|
WO1998037077A1
(en)
|
1997-02-24 |
1998-08-27 |
Zymogenetics, Inc. |
Calcitonin mimetics
|
|
US6160134A
(en)
|
1997-12-24 |
2000-12-12 |
Bristol-Myers Squibb Co. |
Process for preparing chiral cyclopropane carboxylic acids and acyl guanidines
|
|
DE69934093T2
(de)
|
1998-01-27 |
2007-06-21 |
Aventis Pharmaceuticals Inc. |
SUBSTITUIERTE OXOAZAHETEROCYCLYL FAKTOR Xa HEMMER
|
|
US6268367B1
(en)
|
1998-02-23 |
2001-07-31 |
Zymogenetics, Inc. |
Piperazine derivatives for treating bone deficit conditions
|
|
US6383520B1
(en)
|
1998-06-26 |
2002-05-07 |
Chugai Seiyaku Kabushiki Kaisha |
Fine powder of L-α-aminoadipic acid derivative, oral solid preparations containing the same, and method for treatment of bulk powders
|
|
US6284761B1
(en)
*
|
1999-01-08 |
2001-09-04 |
Neurogen Corporation |
1-phenyl-4-(1-[2-aryl]cyclopropyl)methylpiperazines: dopamine receptor ligands
|
|
NZ512772A
(en)
|
1999-01-08 |
2003-11-28 |
Neurogen Corp |
1-Phenyl-4-(1-[2-aryl]cyclopropyl) methylpiperazines useful as dopamine receptor ligands
|
|
WO2000076993A1
(en)
|
1999-06-16 |
2000-12-21 |
Takeda Chemical Industries, Ltd. |
Benzazepine derivatives, process for the preparation of the same and uses thereof
|
|
WO2001022963A1
(en)
|
1999-09-27 |
2001-04-05 |
Merck & Co., Inc. |
Method of preventing osteoporosis
|
|
SK9742002A3
(en)
|
2000-01-07 |
2003-02-04 |
Transform Pharmaceuticals Inc |
High-throughput formation, identification, and analysis of diverse solid-forms
|
|
US6521619B2
(en)
*
|
2000-06-29 |
2003-02-18 |
Icos Corporation |
Aryl phenylcyclopropyl sulfide derivatives and their use as cell adhesion inhibiting anti-inflammatory and immune suppressive agents
|
|
EP1294685A1
(en)
|
2000-06-29 |
2003-03-26 |
Abbott Laboratories |
Aryl phenycyclopropyl sulfide derivatives and their use as cell adhesion-inhibiting anti-inflammatory and immune-suppressive agents
|
|
WO2002008221A2
(en)
|
2000-07-20 |
2002-01-31 |
Neurogen Corporation |
Capsaicin receptor ligands
|
|
US6888012B2
(en)
|
2000-12-25 |
2005-05-03 |
Ajinomoto Co., Inc. |
Process for producing optically active halohydrin compound
|
|
WO2002068409A1
(en)
|
2001-02-23 |
2002-09-06 |
Merck & Co., Inc. |
N-substituted nonaryl-heterocyclic nmda/nr2b antagonists
|
|
ATE449090T1
(de)
|
2001-07-02 |
2009-12-15 |
High Point Pharmaceuticals Llc |
Substituierte piperazin- und diazepanderivate zur verwendung als histamin h3 rezeptormodulatoren
|
|
US7262185B2
(en)
|
2001-08-08 |
2007-08-28 |
Takeda Chemical Industries Ltd. |
Benzazepine derivative, process for producing the same, and use
|
|
USRE40794E1
(en)
|
2001-09-26 |
2009-06-23 |
Merck & Co., Inc. |
Crystalline forms of carbapenem antibiotics and methods of preparation
|
|
AU2002363236A1
(en)
|
2001-10-30 |
2003-05-12 |
Millennium Pharmaceuticals, Inc. |
Compounds, pharmaceutical compositions and methods of use therefor
|
|
US6861432B2
(en)
*
|
2001-11-23 |
2005-03-01 |
Schering Aktiengesellschaft |
Piperazine derivatives that destabilize androgen receptors
|
|
IL164044A0
(en)
|
2002-03-22 |
2005-12-18 |
Lg Life Sciences Ltd |
New crystalline forms of (2S)-N-5-Äamino(inino)methylÜ-2-thienylmethyl-1-(2R)-2-Ä(carboxsymethyl)aminoÜ-3,3-diphenylpropanoyl-2-pyrrolidinecarboxamide-nh2o
|
|
WO2003103666A2
(en)
|
2002-06-07 |
2003-12-18 |
Altana Pharma Ag |
Novel 4,5-dihydro-imidazo[4,5,1-ij]quinolin-6-ones
|
|
US20040209858A1
(en)
*
|
2002-10-22 |
2004-10-21 |
Bennani Youssef L. |
Cycloalkylamides and their therapeutic applications
|
|
US20040077618A1
(en)
|
2002-10-22 |
2004-04-22 |
Bennani Youssef L. |
Cycloalkylamides and their therapeutic applications
|
|
JPWO2004046110A1
(ja)
|
2002-11-15 |
2006-03-16 |
アステラス製薬株式会社 |
メラニン凝集ホルモン受容体拮抗剤
|
|
AU2003296993A1
(en)
|
2002-12-13 |
2004-07-09 |
Smithkline Beecham Corporation |
Cyclopropyl compounds as ccr5 antagonists
|
|
MXPA05011352A
(es)
|
2003-04-23 |
2005-11-28 |
Glaxo Group Ltd |
Derivados de piperazina y su uso para el tratamiento de enfermedades neurologicas y psiquiatricas.
|
|
ES2350837T3
(es)
|
2003-05-01 |
2011-01-27 |
Bristol-Myers Squibb Company |
Compuestos de pirazol-amida sustituidos con arilo útiles como inhibidores de quinasas.
|
|
TWI339206B
(en)
|
2003-09-04 |
2011-03-21 |
Vertex Pharma |
Compositions useful as inhibitors of protein kinases
|
|
CA2549660A1
(en)
|
2003-12-15 |
2005-06-30 |
Japan Tobacco Inc. |
Cyclopropane compounds and pharmaceutical use thereof
|
|
BRPI0418939A
(pt)
|
2004-07-06 |
2008-04-08 |
Xenon Pharmaceuticals Inc |
derivados de nicotinamida e sua utilização como agentes terapêuticos
|
|
AR050865A1
(es)
|
2004-09-09 |
2006-11-29 |
Sanofi Aventis |
Derivados de 2- morfolino-4-pirimidona
|
|
JP5186213B2
(ja)
|
2004-09-29 |
2013-04-17 |
田辺三菱製薬株式会社 |
タウプロテインキナーゼ１阻害剤としての６−ピリジニル−４−ピリミドン誘導体
|
|
WO2006040192A1
(en)
|
2004-10-15 |
2006-04-20 |
Glaxo Group Limited |
Pyrrolidine derivatives as histamine receptors ligands
|
|
CN101128435A
(zh)
|
2004-12-27 |
2008-02-20 |
阿斯利康(瑞典)有限公司 |
作为代谢型谷氨酸受体激动剂用于治疗神经病学及精神病学病症的吡唑酮化合物
|
|
CA2595882A1
(en)
|
2005-01-26 |
2006-08-03 |
Pharmacia & Upjohn Company Llc |
Thieno [2,3-d] pyrimidine compounds as inhibitors of adp-mediated platelets aggregation
|
|
JP2008530162A
(ja)
|
2005-02-15 |
2008-08-07 |
グラクソ グループ リミテッド |
グルタミン酸受容体を増強する化合物および医薬におけるそれらの使用
|
|
MX2007010076A
(es)
|
2005-02-17 |
2007-10-16 |
Astellas Pharma Inc |
Derivado de heterociclico-1-carboxilato que contiene nitrogeno no aromatico de piridilo.
|
|
EP1874780A1
(en)
|
2005-03-25 |
2008-01-09 |
Pharmacia & Upjohn Company LLC |
4-piperazinylthieno[2,3-d]pyrimidine compounds as platelet aggregation inhibitors
|
|
CA2602538A1
(en)
|
2005-03-28 |
2006-10-05 |
Pharmacia & Upjohn Company Llc |
4-piperazinothieno [2, 3-d] pyrimidine compounds as platelet aggregation inhibitors
|
|
EP1896483A2
(en)
|
2005-03-28 |
2008-03-12 |
Pharmacia & Upjohn Company LLC |
4-piperazinylthieno [2, 3-d] pyrimidine compounds as platelet aggregation inhibitors
|
|
US20080194590A1
(en)
|
2005-03-28 |
2008-08-14 |
Pfizer Inc |
4-Piperazinylthieno [2,3-D] Pyrimidine Compounds as Platelet Aggregation Inhibitors
|
|
JP2009501235A
(ja)
|
2005-07-15 |
2009-01-15 |
シェーリング コーポレイション |
癌処置において有用なキナゾリン誘導体
|
|
TW200740779A
(en)
|
2005-07-22 |
2007-11-01 |
Mitsubishi Pharma Corp |
Intermediate compound for synthesizing pharmaceutical agent and production method thereof
|
|
AU2006275568A1
(en)
|
2005-08-02 |
2007-02-08 |
Neurogen Corporation |
Dipiperazinyl ketones and related analogues
|
|
PL1948607T3
(pl)
*
|
2005-09-16 |
2010-09-30 |
Janssen Pharmaceutica Nv |
Cyklopropyloaminy jako modulatory receptora histaminowego H3
|
|
US8158673B2
(en)
|
2005-10-27 |
2012-04-17 |
Pfizer Inc. |
Histamine-3 receptor antagonists
|
|
BRPI0618076A2
(pt)
|
2005-10-31 |
2011-08-16 |
Janssen Pharmaceutica Nv |
processos para a preparação de derivados de ciclopropil-amida
|
|
NZ593074A
(en)
|
2005-12-21 |
2012-04-27 |
Vertex Pharma |
sulfonamide-pyrrolidone derivatives as Modulators of Ion Channels
|
|
US8119668B2
(en)
|
2005-12-23 |
2012-02-21 |
Nelson Erik B |
Treatment methods employing histamine H3 receptor antagonists, including betahistine
|
|
CA2635719A1
(en)
*
|
2006-01-13 |
2007-07-19 |
F. Hoffmann-La Roche Ag |
Cyclohexyl piperazinyl methanone derivatives and their use as histamine h3 receptor modulators
|
|
CN101384581B
(zh)
|
2006-02-17 |
2013-09-18 |
弗·哈夫曼-拉罗切有限公司 |
作为5ht2/d3调节剂的苯甲酰基-哌啶衍生物
|
|
MX2008011133A
(es)
|
2006-03-01 |
2008-12-18 |
Cementech Pty Ltd |
Matriz para elementos de albañileria y metodo de fabricacion de la misma.
|
|
JP2009132621A
(ja)
|
2006-03-13 |
2009-06-18 |
Ajinomoto Co Inc |
シクロプロピルアミド化合物の製造方法
|
|
AU2007231594A1
(en)
|
2006-03-23 |
2007-10-04 |
Amgen Inc. |
1-phenylsulfonyl-diaza heterocyclic amide compounds and their uses as modulators of hydroxsteroid dehydrogenases
|
|
EP2039689A4
(en)
|
2006-05-26 |
2011-12-28 |
Kaneka Corp |
PROCESS FOR PREPARING OPTICALLY ACTIVE 3-AMINO-2-HYDROXYPROPIONIC ACID CYCLOPROPYLAMID DERIVATIVES AND SALTS THEREOF
|
|
US9108948B2
(en)
*
|
2006-06-23 |
2015-08-18 |
Abbvie Inc. |
Cyclopropyl amine derivatives
|
|
CA2655604C
(en)
*
|
2006-06-23 |
2016-08-09 |
Abbott Laboratories |
Cyclopropyl amine derivatives
|
|
US20100016293A1
(en)
|
2006-07-03 |
2010-01-21 |
Rogier Adriaan Smits |
Quinazolines and Related Heterocyclic Compounds, and Their Therapeutic Use
|
|
EP2056828A4
(en)
|
2006-08-21 |
2010-06-23 |
Merck Sharp & Dohme |
SULFONYLATED PIPERAZINES AS CANNABINOID-1 RECEPTOR MODULATORS
|
|
TW200828371A
(en)
|
2006-09-21 |
2008-07-01 |
Matsushita Electric Industrial Co Ltd |
Chip-type filter
|
|
DE102006056526A1
(de)
|
2006-11-30 |
2008-06-05 |
Archimica Gmbh |
Verfahren zur stereoselektiven Synthese von chiralen Epoxiden durch ADH-Reduktion von alpha-Abgangsgruppen-substituierten Ketonen und Cyclisierung
|
|
US7737149B2
(en)
|
2006-12-21 |
2010-06-15 |
Astrazeneca Ab |
N-[5-[2-(3,5-dimethoxyphenyl)ethyl]-2H-pyrazol-3-yl]-4-(3,5-dimethylpiperazin-1-yl)benzamide and salts thereof
|
|
WO2008147864A2
(en)
*
|
2007-05-22 |
2008-12-04 |
Xenon Pharmaceuticals Inc. |
Methods of using piperazine compounds in treating sodium channel-mediated diseases or conditions
|
|
US8030495B2
(en)
|
2007-05-23 |
2011-10-04 |
Coleman Paul J |
Cyclopropyl pyrrolidine orexin receptor antagonists
|
|
ATE481395T1
(de)
*
|
2007-06-11 |
2010-10-15 |
Hoffmann La Roche |
Cyclohexylderivate
|
|
CN101835750B
(zh)
|
2007-08-22 |
2013-07-17 |
阿斯利康(瑞典)有限公司 |
环丙基酰胺衍生物
|
|
WO2009043784A1
(en)
|
2007-10-04 |
2009-04-09 |
F. Hoffmann-La Roche Ag |
Cyclopropyl aryl amide derivatives and uses thereof
|
|
TW200934772A
(en)
|
2008-01-15 |
2009-08-16 |
Lilly Co Eli |
Crystalline(R)-2-(4-cyclopropanesulphonyl-phenyl)-N-pyrazin-2-yl-3-(tetrahydropyran-4-yl)-propionamide
|
|
DE102008049371A1
(de)
|
2008-03-06 |
2009-09-10 |
Mühlbauer Ag |
Einrichtung mit einem RFID-Transponder in einem elektrisch leitfähigen Gegenstand und Herstellungsverfahren hierfür
|
|
CA2721303C
(en)
|
2008-05-08 |
2016-06-28 |
Evotec Ag |
Azetidines and cyclobutanes as histamine h3 receptor antagonists
|
|
WO2010012650A1
(en)
|
2008-07-28 |
2010-02-04 |
Syddansk Universitet |
Compounds for the treatment of metabolic diseases
|
|
CN101462980B
(zh)
|
2009-01-05 |
2013-01-09 |
扬州天辰精细化工有限公司 |
2，6—二氟苯甲酰胺的工业化生产方法
|
|
TW201039825A
(en)
|
2009-02-20 |
2010-11-16 |
Astrazeneca Ab |
Cyclopropyl amide derivatives 983
|
|
JP5746718B2
(ja)
|
2010-02-18 |
2015-07-08 |
アストラゼネカ・アクチエボラーグＡｓｔｒａｚｅｎｅｃａ Ａｋｔｉｅｂｏｌａｇ |
シクロプロピルアミド誘導体からなる固体形態
|
|
US20110201623A1
(en)
|
2010-02-18 |
2011-08-18 |
Uczynski Michael A |
Crystalline Form Of A Cyclopropyl Benzamide Derivative
|